Home health services provider Amedisys Inc. said Monday that it has agreed to buy Boston-based hospice company Beacon Hospice for about $125 million.
Beacon has 23 free-standing locations and one inpatient unit, serving Massachusetts, Maine, New Hampshire, Rhode Island and Connecticut. Its Maine offices are in Augusta, Bangor, Lewiston, Portland and York.
Amedisys said Beacon’s 2021 revenue was about $80 million.
William F. Borne, the CEO of Amedisys, said Beacon serves as a “great complement to our home health business,” with many of its hospice locations matching the market presence of its existing home health services business. Beacon’s 1,300 average daily patients will increase the number of hospice patients under Amedisys’s care by nearly 40 percent.
Shares of Amedisys slid 50 cents to $34.06 amid a broader market decline.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.